Parvalbumin, a horizontal cell associated calcium-binding protein in retinoblastoma eyes

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 6, 1998, Pages 1044-1048

  Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; MONOCLONAL ANTIBODY; PARVALBUMIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA HORIZONTAL NERVE CELL; RETINOBLASTOMA;

ANTIBODIES, MONOCLONAL; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; HUMANS; IMMUNOENZYME TECHNIQUES; NEURONS; PARVALBUMINS; RETINA; RETINAL GANGLION CELLS; RETINAL NEOPLASMS; RETINOBLASTOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0031978844     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hurwitz RL, Bogenmann E, Font RL, Holcombe V, Clark D. Expression of the functional cone phototransduction cascade in retinoblastoma. J Clin Invest. 1990;85:1872-1878.
2. Gonzalez-Fernandez F, Lopes MBS, Garcia-Fernandez JM, et al. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. Am J Pathol. 1992;141:363-375.
3. Nork TM, Schwartz TL, Doshi HM, Millecchia LL. Retinoblastoma: cell of origin. Arch Ophthalmol. 1995;113:791-802.
4. Virtanen I, Kivelä T, Bugnoli M, et al. Expression of intermediate filaments and synaptophysin show neuronal properties and lack of glial characteristics in Y79 retinoblastoma cells. Lab Invest 1988; 59:649-656.
5. Herman MM, Perentes E, Katsetos CD, et al. Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study. Am J Pathol. 1989;134:115-132.
6. Sano T, Saito H, Saito S, Kagawa N, Hizawa K. Somatostatin-immunoreactive cells in human retina and retinoblastoma. Biomed Res. 1981;2:709-713.
7. Tarlton JF, Easty DL. Immunohistological characterisation of retinoblastoma and related ocular tissue. Br J Ophthalmol. 1990;74: 144-149.
8. He W, Inomata H. Dual immunologic property of S-100 protein in normal eyes and eyes with retinoblastoma: a histopathological and immunohistochemical study of 88 cases. Ophthalmologica 1993; 206:133-138.
9. Yuge K, Nakajima M, Uemura Y, Miki H, Uyama M, Tsubura A. Immunohistochemical features of the human retina and retinoblastoma. Virchows Archiv. 1995;426:571-575.
10. Sang DN, Albert DM. Cathecolamine levels in retinoblastoma. In: Jakobiec FA, ed. Ocular and Adnexal Tumors. Birmingham, AL: Aesculapius; 1978:172-180.
11. Tarkkanen A, Tervo T, Tervo K, Eränkö L, Eränkö O, Cuello AC. Substance P immunoreactivity in normal human retina and in retinoblastoma. Ophthalmic Res. 1983;15:300-306.
12. Ikui H, Tominaga Y, Konomi I, Ueno K. Electron microscopic studies on the histogenesis of retinoblastoma. Jpn J Ophthalmol. 1966;10:282-290.
13. He W, Hashimoto H, Tsuneyoshi M, Enjoji M, Inomata H. A reassessment of histologic classification and an immunohistochemical study of 88 retinoblastomas. A special reference to the advent of bipolar-like cells. Cancer. 1992;70:2901-2908.
14. Tsokos M, Kyritsis AP, Chader GJ, Triche TJ. Differentiation of human retinoblastoma in vitro into cell types with characteristics observed in embryonal or mature retina. Am J Pathol. 1986;123: 542-552.
15. Föhr UG, Weber BR, Müntener M, et al. Human α and β parvalbumins. Structure and tissue-specific expression. Eur J Biochem. 1993;215:719-727.
16. Baimbridge KG, Celio MR, Rogers JH. Clacium-binding proteins in the nervous system. Trends Neurosci. 1992;15:303-308.
17. Seto-Ohshima A. Review: calcium-binding proteins in the central nervous system. Acta Histochem Cytochem. 1994;27:93-106.
18. Ohshima T, Endo T, Onaya T. Distribution of parvalbumin immunoreactivity in the human brain. J Neurol. 1991;238:320-322.
19. 2+ binding properties in the human cerebellar cortex: distribution of parvalbumin and calbindin D-28k immunoreactivity. Anat Embryol. 1992;185:163-167.
20. Endo T, Kobayashi M, Kobayashi S, Onaya T. Immunocytochemical and biochemical localization of parvalbumin in the retina. Cell Tissue Res. 1986;243:213-217.
21. Hamano K, Kiyama H, Emson PC, Manabe R, Nakauchi M, Tohyama M. Localization of two calcium binding proteins, calbindin (28 kD) and parvalbumin (12 kD), in the vertebrate retina. J Comp Neurol. 1990;302:417-424.
22. Sanna PP, Keyser KT, Celio MR, Karten HJ, Bloom FE. Distribution of parvalbumin immunoreactivity in the vertebrate retina. Brain Res. 1993;600:141-150.
23. Nag TC, Wadhwa S. Calbindin and parvalbumin immunoreactivity in the developing and adult human retina. Dev Brain Res. 1996; 93:23-32.
24. Yan X-X. Prenatal development of calbindin D-28K and parvalbumin immunoreactivities in the human retina. J Comp Neurol. 1997;377:565-576.
25. Celio MR, Baier W, Schärer L, de Viragh PA, Gerday C. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium. 1988;9:81-86.
26. 2+-binding site of carp parvalbumin recognized by monoclonal antibody. Cell Calcium. 1990;11:19-23.
27. Kivelä T, Tarkkanen A, Virtanen I. Synaptophysin in the human retina and retinoblastoma. An immunohistochemical and western blotting study. Invest Ophthalmol Vis Sci. 1989;30:212-219.
28. Radnót M. On the histogenesis of retinoblastoma. J Pediatr Ophthalmol. 1975;12:259-263.
29. del Cerro M, Notter MF, Seigel G, Lazar E, Chader G, del Cerro C. Intraretinal xenografts of differentiated human retinoblastoma cells integrate with the host retina. Brain Res. 1992;583:12-22.